课题基金 / 基金详情

PHYSIOLOGY OF RELAXIN-INSULIN-LIKE FACTORS

PHYSIOLOGY OF RELAXIN-INSULIN-LIKE FACTORS
松弛素胰岛素样因子的生理学
批准号:
6261321
负责人:
SHEAU-YU Teddy HSU
金额:
$7.85万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-12 至 2003-02-28

项目摘要

项目成果

SHEAU-YU Teddy HSU的其他基金

相似基金

相关文献

中文摘要
翻译
描述:(根据申请者的描述改编):最近的研究 研究表明,哺乳动物的胰岛素/松弛蛋白家族由AT组成 至少6个成员,包括胰岛素、IGF-I、IGF-II和松弛素,以及 一种源于间质细胞的松弛素样多肽(RLF或INSL3)和早期的 胎盘胰岛素样肽(EPIL或INSL4)。胰岛素和IGFS是必不可少的 生长因子对多种细胞有丝分裂、分化和血管生成的影响 细胞谱系。松弛素主要由生殖组织产生, 被发现对乳腺发育和子宫肌层活动很重要。 最近发现的RLF和Epil被证明主要是由 性腺和胎盘。而已知的胰岛素和胰岛素样生长因子在 它们通过特定的受体发挥作用,这些受体可能是松弛素的受体, RLF和Epil还没有被隔离。然而,一种孤儿受体(IRR: 胰岛素受体相关受体)与胰岛素受体相似 已经被确认,这表明还有其他的配体属于 胰岛素/松弛素超家族。基于成熟胰岛素的序列同源性 和松弛素,申请人已经分离出两个新的松弛素/胰岛素样因子 (RIF-1和RIF-2)。Northern杂交和免疫组织化学研究 已经证明Rifi可能参与了睾丸功能的调节 而RIF-2可能在睾丸、肾脏、心脏和 大脑。为了表征这些新型配体的功能重要性, 申请人建议使用标记的合成物建立RIF放射免疫系统 RIF多肽作为示踪剂及鉴定天然成熟RIF蛋白 通过直接测序进行测序。这个实验有两个目的:1) 定义天然RIF蛋白的蛋白降解加工位点,以及2) 产生大量成熟的RIF蛋白,用于鉴定 推测为RIF受体。预计这项研究将导致 两种新型松弛素/胰岛素样配体的结构表征 并为进一步阐明其生物学特性奠定了基础 生理功能。此外,从建议中收集的知识 实验将有助于诊断和治疗与 这些新的松弛素/胰岛素样因子的功能障碍。
英文摘要
DESCRIPTION: (Adapted from applicant's description): Recent studies have shown that the mammalian insulin/relaxin family of proteins consists of at least six members including insulin, IGF-I, IGF-II, and relaxin, together with a relaxin-like peptide of Leydig cell origin (RLF or INSL3) and an early placenta insulin-like peptide (EPIL or INSL4). Insulin and IGFs are essential growth factors for mitogenesis, differentiation, and angiogenesis of diverse cell lineages. Relaxin, which is mainly produced by reproductive tissues, was found to be important for mammary gland development and myometrial activity. The recently identified RLF and EPIL have been shown to be mainly produced by gonads and placenta, respectively. While insulin and IGFs are known to mediate their actions through specific receptors, the putative receptors for relaxin, RLF and EPIL, have not been isolated. However, an orphan receptor (IRR: Insulin Receptor-related Receptor) showing similarity to the insulin receptor has been identified, suggesting that there are additional ligands belonging to the insulin/relaxin superfamily. Based on sequence homology to mature insulin and relaxin, the applicant has isolated two novel Relaxin/Insulin-like Factors (RIF-1 and RIF-2). Northern blot hybridization and immunohistochemical studies have shown that RIFI could be involved in the regulation of testis function whereas RIF-2 may have a role in the function of testis, kidney, heart, and brain. To characterize the functional importance of these novel ligands, the applicant proposes to establish RIF radioimmunoassys using a labeled synthetic RIF polypeptide as the tracer and to identify native mature RIF protein sequences through direct sequencing. This experiment has dual purposes: 1) to define the proteolytic processing sites of native RIF proteins, and 2) to produce large quantities of mature RIF proteins for characterizing the putative RIF receptors. It is anticipated that this study would lead to the delineation of the structure of two novel relaxin/insulin-like ligands derived from testis and provide the basis for future elucidation of their physiological functions. Additionally, knowledge gathered from the proposed experiments would help the diagnosis and treatment of diseases associated with the dysfunction of these novel relaxin/insulin-like factors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A therapy for improving diabetic ulcer healing
  • 批准号:
    10820107
  • 项目类别:
  • 资助金额:
    $33.53万
  • 财政年份:
    2023
  • 负责人:
    SHEAU-YU Teddy HSU
  • 依托单位:
Novel Therapeutics for Endothelial Dysfunction
  • 批准号:
    9253486
  • 项目类别:
  • 资助金额:
    $29.04万
  • 财政年份:
    2017
  • 负责人:
    SHEAU-YU Teddy HSU
  • 依托单位:
Developing Novel Therapies for Treating Breast-Cancer-Related Lymphedema
  • 批准号:
    8647758
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2014
  • 负责人:
    SHEAU-YU Teddy HSU
  • 依托单位:
Prevention of Preeclampsia-associated preterm births
  • 批准号:
    8780971
  • 项目类别:
  • 资助金额:
    $22.5万
  • 财政年份:
    2014
  • 负责人:
    SHEAU-YU Teddy HSU
  • 依托单位:
海外基金